Oceania · Financial press · Australian Financial Review
CSL names British pharma executive as new CEO
The appointment ends months of uncertainty for the blood plasma giant, which fell out of favour with investors after a string of earnings downgrades and impairments.
Read the full article on Australian Financial Review Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.afr.com)